Search

How Can We Help You?

Video

Quick Info:

Find a Doctor Specialties (800) 213-3284

Select Clinical Trial

Protocol Number: NRG HN009

Protocol Title: Randomized phase II/III trial of radiation with high-does Cisplatin (100 mg/m²) every three weeks versus radiation with low-does weekly Cisplatin (40 mg/m²) for patients with locoregionally advanced squamous cell carcinoma of the head and neck.

Eligibility: Men or women age 18 and older with squamous cell cancer of the head and neck without distant metastasis.

Contact Information: (910) 715-2200

____________________________________________________________________________________________

Protocol Number: NRG HN005

Protocol Title: De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

Eligibility: Oropharyngeal squamous cell carcinoma, p-16 +, < or = to 10 pack year smoking, Stage I-II

Contact Information: (910) 715-2200

____________________________________________________________________________________________

Specialties
Clara McLean House
Make a Donation
News & Events